Refine by
Cardiopulmonary Articles & Analysis
20 news found
The program began with a detailed session on Basic Life Support (BLS) / CPR (Cardiopulmonary Resuscitation) performing chest compressions and rescue breathing, a vital skill that can make a difference in life-threatening situations. ...
Suspected malignant lesions at the treatment site. 6. Poor cardiopulmonary function and organic lesions of important organs. 7. Pregnant and lactating women. ...
It also provides validation that Third Pole’s technology represents the best in class, tankless nitric oxide portable systems to improve acute and chronic cardiopulmonary patient outcomes.” “I am also pleased to report that eNOfit™, our novel miniaturized mobile-wearable nitric oxide device designed to provide ’on-the-go’ treatment for ...
The DrugSorb™-ATR Antithrombotic Removal System, which is based on the same polymer technology as CytoSorb, has also been granted FDA Breakthrough Designation for the removal of ticagrelor, as well as FDA Breakthrough Designation for the removal of the direct oral anticoagulant (DOAC) drugs, apixaban and rivaroxaban, in a cardiopulmonary bypass circuit during urgent ...
The DrugSorb™-ATR Antithrombotic Removal System, which is based on the same polymer technology as CytoSorb, has also been granted FDA Breakthrough Designation for the removal of ticagrelor, as well as FDA Breakthrough Designation for the removal of the direct oral anticoagulant (DOAC) drugs, apixaban and rivaroxaban, in a cardiopulmonary bypass circuit during urgent ...
The DrugSorb™-ATR Antithrombotic Removal System, which is based on the same polymer technology as CytoSorb, has also been granted FDA Breakthrough Designation for the removal of ticagrelor, as well as FDA Breakthrough Designation for the removal of the direct oral anticoagulant (DOAC) drugs, apixaban and rivaroxaban, in a cardiopulmonary bypass circuit during urgent ...
Based on the universal endorsements eNOcareTM has received from cardiopulmonary critical care centers around the world, Third Pole expects rapid adoption and significant market expansion soon after launch given its superior safety, usability and reliability features compared with other product alternatives. ...
This device creates a revolutionary advantage that will dramatically expand inhaled nitric oxide therapy by making it practical to treat a wide variety of life-limiting cardiopulmonary diseases in any setting, including the more than 1.2M patients struggling at home with severe COPD and ILD (e.g., pulmonary fibrosis). ...
The DrugSorb™-ATR Antithrombotic Removal System, which is based on the same polymer technology as CytoSorb, has also been granted FDA Breakthrough Designation for the removal of ticagrelor, as well as FDA Breakthrough Designation for the removal of the direct oral anticoagulant (DOAC) drugs, apixaban and rivaroxaban, in a cardiopulmonary bypass circuit during urgent ...
The DrugSorb™-ATR Antithrombotic Removal System, which is based on the same polymer technology as CytoSorb, has also been granted FDA Breakthrough Designation for the removal of ticagrelor, as well as FDA Breakthrough Designation for the removal of the direct oral anticoagulant (DOAC) drugs, apixaban and rivaroxaban, in a cardiopulmonary bypass circuit during urgent ...
CytoSorbents’ CytoSorb® therapy is the only treatment approved to remove ticagrelor during cardiopulmonary bypass in the E.U. The DrugSorb-ATR™ Antithrombotic Removal system is based on the same polymer technology as CytoSorb®. ...
This is being performed under the previously announced FDA Breakthrough Device Designation granted to the DrugSorb–ATR™ Antithrombotic Removal System for the removal of apixaban (Eliquis®, Bristol-Myers Squibb/Pfizer) and rivaroxaban (Xarelto®, Janssen/Bayer) in a cardiopulmonary bypass circuit to reduce the likelihood of serious perioperative bleeding in ...
Hemodynamic data from a cohort of 10 patients implanted with the deviceduring the European PIVOTAL study, recorded over 1,842 support days in auto-mode, were analyzed with respect to daily changing physiologic needs.The device was successfully switchedfrom manual mode to auto-mode in the operating room, following weaning from cardiopulmonary bypass (CPB), in all ...
ByCarmat
The investigators concluded that although intraoperative hemoadsorption reduced plasma cytokines at the end of cardiopulmonary bypass, it did not reduce the severity of post-operative organ dysfunction as observed by the change in mean SOFA (Sequential Organ Failure Assessment) score over nine days. ...
In a pilot study of 30 adult patients undergoing cardiac surgery with cardiopulmonary bypass, she found that over half of the patients had elevated intra-abdominal pressures for more than 6 hours and that there was an association between high intra-abdominal pressures and acute kidney injury (AKI). ...
The innovative solutions include a contact-free in-home multiparameter health sensing system for chronic cardiopulmonary diseases to a comprehensive professional-grade VR medical simulation system to train physicians, nurses, and other allied health professionals. ...
The technology may also be used with other devices or treatments such as CRRT, ECMO, cardiopulmonary bypass, organ transplants and immunomodulating therapeutics. ...
Actelion is a leader in the science and treatment of pulmonary arterial hypertension (PAH), a long-term, life-threatening cardiopulmonary disorder characterized by abnormally high blood pressure within the arteries in the lungs. The goal of this collaboration is to leverage Actelion’s expertise in pharmaceuticals and cardiopulmonary products, along with its ...
” While Invizius’s first product is aimed at kidney dialysis, there is also potential to use the technology with other devices or procedures such as cardiopulmonary bypass, catheters, stents, organ transplants and vascular grafts. ...
Reactions can range from minor to serious and include dermal, gastrointestinal and cardiopulmonary responses. One of the leading food testing companies providing allergen testing services in North America is EMSL Analytical, Inc. ...